ACHV
Price
$2.07
Change
-$0.11 (-5.05%)
Updated
Jul 7 closing price
Capitalization
102.85M
30 days until earnings call
ALT
Price
$4.43
Change
-$0.33 (-6.93%)
Updated
Jul 7 closing price
Capitalization
359.3M
30 days until earnings call
Interact to see
Advertisement

ACHV vs ALT

Header iconACHV vs ALT Comparison
Open Charts ACHV vs ALTBanner chart's image
Achieve Life Sciences
Price$2.07
Change-$0.11 (-5.05%)
Volume$1.69M
Capitalization102.85M
Altimmune
Price$4.43
Change-$0.33 (-6.93%)
Volume$6.13M
Capitalization359.3M
ACHV vs ALT Comparison Chart in %
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. ALT commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a StrongBuy and ALT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (ACHV: $2.07 vs. ALT: $4.43)
Brand notoriety: ACHV and ALT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 227% vs. ALT: 119%
Market capitalization -- ACHV: $102.85M vs. ALT: $359.3M
ACHV [@Biotechnology] is valued at $102.85M. ALT’s [@Biotechnology] market capitalization is $359.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileALT’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ALT’s FA Score: 0 green, 5 red.
According to our system of comparison, ALT is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while ALT’s TA Score has 5 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 6 bearish.
  • ALT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALT is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -8.41% price change this week, while ALT (@Biotechnology) price change was +14.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +12.24%, and the average quarterly price growth was -0.68%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 06, 2025.

ALT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($359M) has a higher market cap than ACHV($103M). ALT YTD gains are higher at: -38.558 vs. ACHV (-41.193). ACHV has higher annual earnings (EBITDA): -44.37M vs. ALT (-90.75M). ALT has more cash in the bank: 150M vs. ACHV (23.2M). ALT has less debt than ACHV: ALT (1.59M) vs ACHV (9.96M). ALT has higher revenues than ACHV: ALT (20K) vs ACHV (0).
ACHVALTACHV / ALT
Capitalization103M359M29%
EBITDA-44.37M-90.75M49%
Gain YTD-41.193-38.558107%
P/E RatioN/AN/A-
Revenue020K-
Total Cash23.2M150M15%
Total Debt9.96M1.59M628%
FUNDAMENTALS RATINGS
ACHV vs ALT: Fundamental Ratings
ACHV
ALT
OUTLOOK RATING
1..100
5126
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9364
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (69) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew similarly to ALT’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as ACHV (99) in the Biotechnology industry. This means that ALT’s stock grew similarly to ACHV’s over the last 12 months.

ALT's Price Growth Rating (64) in the Miscellaneous Commercial Services industry is in the same range as ACHV (93) in the Biotechnology industry. This means that ALT’s stock grew similarly to ACHV’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as ACHV (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVALT
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSHK0.110.01
+7.39%
Drive Shack Inc.
MOGLF0.830.02
+2.14%
Mongolian Mining Corp.
FMCQF57.07N/A
N/A
Fresenius Medical Care AG
DRXGY18.41N/A
N/A
Drax Group Plc
GUELF0.12N/A
N/A
GLOBAL URANIUM & ENRICHMENT LTD.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-5.05%
ALT - ACHV
57%
Loosely correlated
-6.93%
ABOS - ACHV
38%
Loosely correlated
N/A
NAUT - ACHV
37%
Loosely correlated
-2.93%
EYPT - ACHV
37%
Loosely correlated
-1.76%
ARCT - ACHV
37%
Loosely correlated
-3.05%
More

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-6.93%
ACHV - ALT
57%
Loosely correlated
-5.05%
INDP - ALT
45%
Loosely correlated
+0.18%
INMB - ALT
42%
Loosely correlated
-9.09%
IDYA - ALT
41%
Loosely correlated
-4.25%
KROS - ALT
39%
Loosely correlated
-0.37%
More